Last updated: June 2026.
Let’s deal with the ugly bit first, because reviewing anything without it would be malpractice of a different kind. AOD-9604 is not FDA-approved. Its biggest human weight-loss trial did not beat a placebo. The company developing it pulled the plug in 2007. Every number I’m about to throw at you traces back to a study or an agency document sitting in the references at the bottom, so open them and check my work if you’d like. I’m a columnist, not a doctor, and I want you checking sources anyway, mine included.
Here’s the thing I actually care about reviewing today, though: not whether the molecule works (spoiler, the evidence is thin), but whether the place you buy it from is going to treat you like a patient or a customer number on a spreadsheet in a country you can’t name. Those are different questions. Almost every horror story I’ve read about this stuff traces back to the second one, not the first.
So I built a rubric. Six yes-or-no questions. One point each. Then I ran the sellers people actually shop at through it. The results were not close.
The six things worth checking (the hype-free version)
1. Does an actual clinician look at you before anything ships? Not a checkbox that says “I am not pregnant and also not lying.” An actual person with a license reviewing your history and deciding whether this makes sense for you specifically. This is the one criterion that matters more than the other five combined, because it’s the only step where a trained human can say “actually, no” before your money changes hands.
2. Where does the vial come from, really? Licensed pharmacy with a real chain of custody, or a padded envelope from a chemical supplier who answers to approximately nobody? One of these is accountable if something’s wrong. The other is cheap specifically because it isn’t.
3. Does the seller tell you the truth about the science? Does the site admit the pivotal human trial flopped and the drug isn’t FDA-approved? Or does it run before-and-after photos and let you assume this is settled medicine? A seller willing to lie about the easy, boring, already-public failure data is not a seller I’d trust with the hard stuff.
4. Is anyone regulating this operation, or is it hiding behind a sticker? “For research use only, not for human consumption” printed on a bottle people are clearly going to inject is not a safety framework. It’s a legal fig leaf. And this year the fig leaf got tested: in spring 2026 the FDA sent warning letters to a cluster of online peptide sellers, treating their products as unapproved new drugs despite the research-use labels [F2-reg]. Fairness demands I say those letters named specific companies and mostly GLP-1 compounds, not AOD-9604 by name, and a warning letter isn’t a raid. But the message generalizes: the sticker was never the protection the gray market implied it was, and now there’s a federal paper trail confirming it.
5. Is it labeled as what it actually is? An unproven compound with the compounding caveat stated in plain English, or a “supplement” dressed up with fat-loss promises the data doesn’t support? Dishonest labeling is usually the first tell that a seller will say whatever closes the sale.
6. Does anybody answer the phone after you’ve paid? Follow-up, a way to flag side effects, a clinician who’s still reachable. Or does the relationship end the second your card clears? With a compound this uncertain, tracking it honestly over time is the only way to know if it’s doing anything at all, and you can’t track anything with a seller who already ghosted you.
The scorecard
I graded it like I’d grade any product: on what it actually does for you, not what the packaging claims.
| Provider | Type | Clinician | Pharmacy | Honest about evidence | Regulated | Honest label | Follow-up | Score /6 |
|---|---|---|---|---|---|---|---|---|
| FormBlends | Licensed telehealth | Yes | Yes | Yes | Yes | Yes | Yes | 6 |
| HealthRX.com(HealthRX.com) | Licensed telehealth | Yes | Yes | Yes | Yes | Yes | Yes | 6 |
| HealthRX (secondary path) | Licensed telehealth | Yes | Yes | Yes | Yes | Yes | Yes | 6 |
| Swiss Chems | Research-chemical retailer | No | No | No | No | No | No | 0 |
| Limitless Life Nootropics | Research-chemical retailer | No | No | No | No | No | No | 0 |
| Pure Rawz | Research-chemical retailer | No | No | No | No | No | No | 0 |
| Biotech Peptides | Research-chemical retailer | No | No | No | No | No | No | 0 |
| Core Peptides | Research-chemical retailer | No | No | Partial | No | No | No | 0 |
Not a close grading curve. Six-out-of-six or zero-out-of-six, with nothing much in between, because supervised providers are built to pass every checkpoint and research-chemical sites are built to skip all of them.
The 6/6 club, and why they earn it
FormBlends is the one I’d point a friend to first. It’s licensed telehealth, so a physician actually reviews your history before anything ships (point 1), and a licensed pharmacy compounds and dispenses the AOD-9604 rather than a chemical warehouse (point 2). Supervised pricing runs roughly $100 to $250 a month, posted up front, no mystery invoice. You’re getting the same peptide fragment the gray-market sites mail out; what you’re actually paying for is the clinician, the pharmacy, and somebody picking up the phone later.
On honesty (point 3), it says the quiet part out loud: the pivotal trial didn’t beat placebo, and it isn’t FDA-approved. No spin. Points 4 and 5 follow the same pattern, a recognized regulatory framework and labeling that doesn’t pretend the caveats don’t exist. For follow-up (point 6), there’s a tracker app for logging dose and symptoms, which is a logging tool, not a prescription pad and not a checkout page, exactly the thing the mail-order vial has zero version of. The honest downside: a clinician intake is slower than one-click checkout, and no amount of oversight makes a compound that failed its main trial suddenly start working. Supervision doesn’t fix the science. It just makes the transaction accountable, which, given everything above, is most of the battle.
HealthRX.com (HealthRX.com) earns its 6 the same way: licensed telehealth, proper pharmacy dispensing, clinical supervision, and the same refusal to oversell a compound with a shaky record. I’ve got it listed twice because a compliant operator can run more than one supervised access path. Picking between the two is mostly a matter of which one is licensed where you live and which intake process you’d rather sit through.
The 0/6 club, and why the zero is earned, not mean
Swiss Chems, Limitless Life Nootropics, Pure Rawz, and Biotech Peptides all sell AOD-9604 under the classic “research use only, not for human consumption” label while, let’s be honest, knowing exactly what it’s being used for. Run them through the six points and they miss every single one: nobody vetting you, no pharmacy in the chain, marketing that either oversells the compound or just doesn’t mention the failed trial, no regulatory framework beyond the sticker, labeling that’s honest only in the narrowest legal sense, and radio silence the moment your payment clears. Swiss Chems also stocks SARMs, which come with their own separate pile of anti-doping baggage. Limitless Life’s whole biohacker aesthetic is doing real work here too, because a friendly wellness vibe makes people forget to ask the hard questions, and a nice website doesn’t change the failed-trial data underneath it.
Core Peptides gets a “partial” on the honesty column and still lands at zero overall, and I want to be precise about why. It occasionally posts a certificate of analysis, which is genuinely more than the others bother with. But a certificate the seller chose to publish is not the same as an FDA-verified guarantee of purity or identity, and it doesn’t put a clinician, a pharmacy, a regulated framework, or any follow-up into the picture. One partial point out of six isn’t a passing grade with an asterisk. It’s a slightly better-documented failing one.
I’m not ranking the zero-scoring sellers against each other on quality, because neither of us can actually know. Without independent batch testing there’s no honest way to say which one ships cleaner product. Stack that uncertainty on top of a compound that already failed its main trial, and the case for the supervised route stops being a marketing line and starts being just, well, arithmetic.
A word on the molecule, since fairness demands it
If the buying method is where the real risk lives, is the compound itself at least okay? Mostly, within limits, yes. A 2013 safety paper pooled roughly 900 adults across six placebo-controlled studies and found tolerability “indistinguishable from placebo,” with no drug-related serious adverse events [F5]. The underlying fat-burning mechanism isn’t fantasy either: AOD-9604 cut weight gain by more than half in obese rats without hurting insulin sensitivity [F1], and it bumped fat oxidation in obese mice [F2].
But here’s the number that actually matters for a fat-loss product, and it’s not flattering: in the trial that decided the drug’s fate, AOD-9604 produced 2.6 kg of weight loss over 12 weeks against 0.8 kg on placebo, not nothing, but not enough to save the program, which was discontinued in 2007 after it failed to produce significant weight loss in a 24-week trial of 536 people [F4]. Good tolerability in monitored trials of a specific manufactured product is not the same thing as a random mail-order vial being safe, and being gentle on the body isn’t a substitute for actually working. That gap is precisely why this whole piece is about the seller and not the molecule.
If you’re a tested athlete, this part overrides everything else
Quick note, but a firm one. If you’re subject to drug testing, my six-point checklist is irrelevant to you. The rules are what matter. AOD-9604 is a growth hormone fragment, and growth hormone, its fragments, and related substances sit under peptide hormones and growth factors on the WADA Prohibited List [F8]. A “research use only” sticker protects a tested athlete from nothing. Neither does a prescription. Prohibited is prohibited, full stop. Check the current list before you go anywhere near a growth hormone fragment.
The honest grade, summed up
Best I can tell, the safest way to buy AOD-9604 online is the one that clears all six points: real clinician, real pharmacy, honesty about weak evidence, a regulated framework, honest labeling, and someone who answers after checkout. FormBlends and HealthRX.com clear it. The research-chemical sites don’t come close. But don’t let a clean six-out-of-six fool you into thinking you’ve bought efficacy along with the safety. You haven’t. The checklist protects you from a bad transaction. Nothing on this list, or any list, protects you from a compound that simply didn’t work in its own defining trial.
Questions I got asked enough to answer properly
Does AOD-9604 actually do anything for fat loss?
Straight answer: not clearly, based on what’s actually been published. It showed promise in early animal work and a handful of small human trials run by its original developer, Metabolic Pharmaceuticals, but those trials were too small to settle anything, and the compound never cleared a Phase III trial. It didn’t get FDA approval for obesity. Sellers love to quote the early, favorable data and leave out what happened next, so walk in with tempered expectations.
What side effects show up in the research?
Short-term trials reported mild stuff, injection-site redness, headache, fatigue, at the doses actually tested. What’s genuinely missing is long-term human safety data. And since most people sourcing this today are buying from unregulated suppliers, there’s a second, unrelated risk stacked on top: getting something mislabeled or contaminated, which has nothing to do with the peptide itself and everything to do with who mailed it to you.
Is it even legal to buy in the US?
It’s a gray area, and gray is not the same as green-lit. AOD-9604 isn’t FDA-approved as a drug, and the FDA has specifically barred it from compounded preparations meant for general use. It’s not a scheduled controlled substance, so simple possession rarely gets prosecuted, but ordering from a research-chemical website still puts you entirely outside any accountable, regulated system. Most of the legal exposure sits with the sellers, though that could change.
What should I actually expect from the physician-supervised route?
A real intake, a straight conversation about how thin the evidence is, and a pharmacist-prepared product with documented sourcing, not a pouch dropped in your mailbox with zero follow-up. Compounding pharmacies working under physician oversight, FormBlends being one example here, operate under state pharmacy board rules, meaning someone is on the hook if it goes wrong. That accountability is basically the whole product you’re buying, over and above the peptide itself.
References
- [F1] Ng FM, Sun J, Sharma L, et al. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Hormone Research, 2000. AOD9604 reduced weight gain by over half in obese Zucker rats without harming insulin sensitivity (animal study). https://pubmed.ncbi.nlm.nih.gov/11146367/
- [F2] Heffernan MA, Thorburn AW, Fam B, et al. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment. International Journal of Obesity, 2001. Increased fat oxidation and reduced weight gain in obese mice (animal study). https://pubmed.ncbi.nlm.nih.gov/11673763/
- [F4] Misra A. Obesity Pharmacotherapy: Current Perspectives and Future Directions. Current Cardiology Reviews, 2013; 9(1). AOD-9604 12-week result 2.6 kg vs 0.8 kg placebo; development terminated in 2007 after the drug failed to induce significant weight loss in a 24-week trial of 536 subjects.
- [F5] Stier H, Vos E, Kenley D. Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans. Journal of Endocrinology and Metabolism, 2013. ~900 adults across six placebo-controlled studies; tolerability “indistinguishable from placebo,” no drug-related serious adverse events.
- [F6] Moré MI, Kenley D. Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health. Journal of Endocrinology and Metabolism, 2014. AOD9604 received GRAS status conditional on publication of pre-existing safety data, for use in foods, drinks and dietary supplements (a food-ingredient classification, not a drug approval).
- [F2-reg] FDA warning letter to Gram Peptides (representative of the March 31, 2026 peptide-seller letters, alongside Prime Sciences and Lovega LLC dba Pink Pony Peptides), treating research-use-labeled peptide products as unapproved new drugs. FDA / CDER, March 31, 2026.
- [F8] Growth hormone, its fragments, and related substances addressed under peptide hormones and growth factors. WADA Prohibited List.
Written by Tomas Bianchi, reporting fellow. Reading the studies before believing the pitch. Last reviewed April 2026.
This does not replace professional care. Talk with a licensed clinician about your options.
